Company Overview and News

Sensex down 61 points in opening trade

Mumbai: The BSE Sensex slipped almost 61 points in opening trade today on heavy selling in metals, realty energy and auto stocks amid sustained capital outflows by foreign funds.

Podcast | Sensex snaps 5-day losing streak; Nifty closes below 100-DMA

2018-05-22 moneycontrol
The S&P BSE Sensex snapped its 5-day losing streak and closed in positive making a small bullish candle on the daily candlestick charts on Tuesday. The Nifty50 also held on to its crucial support level placed at 10,500 levels, but closed below its 100-days moving average placed around 10,540.

Market Live: Sensex, Nifty Bank slip over 100 pts; HUL pips ITC in market cap

2018-05-18 moneycontrol
Fund Raising: Infrastructure firm NCC said its board will meet next week to consider raising funds through issuance of equity shares or warrants to promoters on preferential basis.

Sensex extends losses on foreign fund outflows, rising oil prices

Mumbai: The BSE Sensex drifted lower by another 125 points in early trade today amid unabated foreign fund outflows and surging global crude oil prices. The rupee depreciating against the US dollar also affected momentum.

Market Live: Sensex down over 100 pts; Bajaj Fin extends gains, Bajaj Auto top gainer

2018-05-18 moneycontrol
Market Update: The market continued trade lower, with the Sensex falling more than 100 points amid higher crude oil prices and corporate earnings.

Market Live: Sensex breaks 35K, down over 150 pts; all sectoral indices in the red

2018-05-18 moneycontrol
Market Update: The market extended opening losses, continuing correction for the fourth consecutive session amid higher crude oil prices, weak rupee.

Most FMCG firms beat Street math in Q4

2018-05-16 thehindubusinessline
Priya Kansara The consumer sector is among the few in the economy on which analysts and investors have pinned high hopes for a strong financial performance in the March quarter. And not without reason, given the low base of the post-demonetisation period and better macro environment compared to other industries.

Market Live: Sensex trades lower, Nifty hovers around 10800; midcaps, auto stocks fall

2018-05-14 moneycontrol
Some weakness is now seen on the D-Street as it gets ready for the outcome of Karnataka assembly polls on Tuesday. The Sensex is down over 50 points, while the Nifty is trading around 10,780-levels. Midcaps have further extended their fall, pharma and PSU banks have trimmed some of the gains. Auto stocks too continued to trade lower. Dr Reddy’s Labs, NTPC, and SBI were the top gainers, while Tata Motors, M&M, Titan and Indiabulls Housing were the top losers.

Market Live: Nifty volatile, Midcap falls 1% on caution ahead of Karnataka poll results

2018-05-14 moneycontrol
Earnings: Kerala-based private sector lender South Indian Bank has reported massive 51.1 percent growth year-on-year in net profit at Rs 114.1 crore for the quarter ended March 2018.

Market Live: Sensex off day#39;s high as traders cautious ahead of Karnataka poll results

2018-05-14 moneycontrol
Inflation: Wholesale Price Index inflation increased to 3.18 percent in the month of April compared to 2.47 percent in previous month.

Market Live: Sensex gains strength ahead of Karnataka poll results; midcaps underperform

2018-05-14 moneycontrol
Market Update: The market gained some strength in morning, with the Nifty holding 10,800 levels ahead of Karnataka election results due tomorrow.

Market Live: Nifty opens above 10,800, Sensex flat after Karnataka exit polls

2018-05-14 moneycontrol
Market Update: The market is trading in a tight range of around 20 points on the Nifty. Traders prefer to await Karnataka elections results before taking any big positions as exit polls announced on Saturday indicated hung assembly.

Asian markets up on US-China thaw, Malaysian shares bounce, ringgit falls

2018-05-14 thehindubusinessline
Asian shares shot up to near two-month highs on Monday on signs the United States and China were toning down their trade war rhetoric, while Malaysian Ringgit hit a four-month trough in the first onshore trade since a shock election result last week.

Nine of top-10 most valued firms add Rs 65,129 cr in m-cap

2018-05-13 thehindubusinessline
Nine of the top-10 most valued Indian companies together added Rs 65,128.77 crore in market capitalisation (m-cap) last week, with RIL recording the maximum surge in its valuation. Tata Consultancy Services (TCS) was the only one to see erosion from its m-cap, while the rest nine companies, including HDFC Bank, ITC, Hindustan Unilever Ltd (HUL) and HDFC registered gains.

Company news: Sical Logistics

2018-05-11 thehindubusinessline
The board of directors of Sical Logistics on Friday approved a proposal to purchase the 11 per cent stake held by L&T Infrastructure Development Projects in Sical Iron Ore Terminals, its subsidiary. The decision is subject to regulatory approvals, it said. Shares of Sical Logistics closed flat at ₹205.20 on the BSE.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...